PROMEDIX, INC.
SBIR Phase II: Electronic Measurement Device of Capillary Refill Time to Improve Outcomes from Sepsis
PROMEDIX, INC. is a company in biomedical engineering based in PORTLAND, OR, founded in 2018.
Profile
ProMedix “FlowSense” rapidly and noninvasively identifies worsening peripheral blood flow, one of the earliest physiological indications of sepsis. FlowSense monitors changes in the capillaries of the fingertips, indicating impaired circulation; facilitating earlier therapeutic interventions by physicians and improving patient outcomes.
The company sits in the biomedical engineering segment, where it competes on its core product or service.
The company is recorded as being based in PORTLAND, OR.
The company is listed at the SBIR Phase II stage of development.
Public records show total funding of about $1.1M.
| Sector | BIOMEDICAL ENGINEERING |
|---|---|
| Headquarters | PORTLAND, OR |
| Country | United States |
| Founded | 2018 |
| Stage | SBIR Phase II |
| Total funding | $1,144,758 |
Website: www.promedixinc.com
Browse related
Create a free account